Author name: Manuela Vidolova

HistoIndex Secures SGD 9 Million Investment to Drive Next Phase of Expansion SINGAPORE, May 2, 2025 /PRNewswire/ — HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next …

HistoIndex Secures SGD9 Million Investment to Drive Next Phase of Expansion Read More »

A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ SINGAPORE, March 17, 2025 /PRNewswire/ — HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory Developed Test (LDT) FibroSIGHT™ – now available in the United States. This marks a significant milestone …

A New Standard in Clinical Care for MASH Patients: HistoIndex Launches FibroSIGHT™ Read More »

BRIDGING CLINICAL RESEARCH AND CLINICAL CARE WITH AI-AIDING PATHOLOGISTS TOOL SINGAPORE, Dec. 9, 2024 /PRNewswire/ — A newly published collaborative study[1] in the Journal of Hepatology, featuring HistoIndex – a global leader in stain-free digital pathology solutions for managing fibrotic diseases – alongside Merck & Co., MSD, Virginia Commonwealth University (VCU), The National Institutes of Health (NIH) and a panel of distinguished international …

Bridging Clinical Research and Clinical Care with AI-aiding Pathologists Tool Read More »